Pharmawings SRL
Pharmawings reported total assets of 7,404 € at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Jul 2026).
The score of Pharmawings shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmawings's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Jul 2026
- Year ended 31 Dec 2024filed on 15 Jul 2025
Pharmawings's financial analysis
- Solvency-35.1%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmawings
Pharmawings's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1000.600.926
- VAT number
- BE1000600926
- Peppol
- Registered · 0208:1000600926 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 02 Oct 2023
- Registered office
- 8740 Pittem
- Latest accounts
- 2025 · filed on 27 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmawings (SRL) has been based in Pittem since 2023, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 2,082 € and equity of −2,596 €; its revenue is not published. Its solvency stands at -35.1%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharmawings
Companies in the same business, of comparable size and area, outside its group.
- Yascare Retail sale of pharmaceutical products Uccle · balance sheet 34,424 €
- Camille Loward Retail sale of pharmaceutical products Beersel · balance sheet 18,302 €
- Grace Partner Retail sale of pharmaceutical products Quaregnon · balance sheet 19,066 €
- Wasopharma Retail sale of pharmaceutical products Nivelles · balance sheet 11,298 €
- LEJV Retail sale of pharmaceutical products Bertrix · balance sheet 34,528 €
- Del Pharma Retail sale of pharmaceutical products Mons · balance sheet 36,943 €
- AFYA Retail sale of pharmaceutical products Grâce-Hollogne · balance sheet 8,634 €
- Codema Pharma Retail sale of pharmaceutical products Brussels · balance sheet 375,959 €
Frequently asked questions about Pharmawings
What is the revenue of Pharmawings?
Pharmawings files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmawings?
In Belgium, the VAT number is the company number prefixed with BE: BE1000600926 for Pharmawings, if the company is VAT-registered. Its company number (CBE) is 1000.600.926.
Where is the registered office of Pharmawings?
According to the CBE register, the registered office of Pharmawings is in 8740 Pittem.
What is the equity of Pharmawings?
At the close of the 2025 financial year, the equity of Pharmawings amounts to -2,596 €, a solvency of -35.1% of total assets.
Who manages Pharmawings?
The register lists 2 active mandates at Pharmawings. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmawings
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →